Belpointe Asset Management’s Cartesian Therapeutics RNAC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-947
| Closed | -$18.5K | – | 916 |
|
|
2024
Q1 | $18.5K | Hold |
947
| – | – | ﹤0.01% | 783 |
|
|
2023
Q4 | $19.6K | Buy |
947
+67
| +8% | +$1.39K | ﹤0.01% | 701 |
|
|
2023
Q3 | $28K | Buy |
+880
| New | +$28K | ﹤0.01% | 645 |
|
|
2023
Q2 | – | Sell |
-321
| Closed | -$13.4K | – | 2765 |
|
|
2023
Q1 | $13.4K | Buy |
321
+30
| +10% | +$1.25K | ﹤0.01% | 2546 |
|
|
2022
Q4 | $9.87K | Buy |
+291
| New | +$9.87K | ﹤0.01% | 2623 |
|